Related Experiment Video
Updated: Jun 28, 2026
08:13
In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
[Myocardial viability: update in nuclear cardiology]
1Departamento de Cardiología Nuclear y Tomografía Cardíaca, Instituto Nacional de Cardiología "Ignacio Chávez", INCICH, Juan Badiano Núm. 1, Colonia Sección XVI, Tlalpan 14080, México, DF.
Archivos De Cardiologia De Mexico
|October 22, 2008
Summary
Radionuclide imaging reliably assesses myocardial viability, integrating molecular, metabolic, and functional data. This aids in stratifying cardiovascular risk for post-myocardial infarction patients before hospital discharge.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Myocardial viability assessment is crucial for risk stratification in post-myocardial infarction patients.
- Coronary risk stratification categorizes patients into low (mortality <1%), intermediate, and high (mortality >3%) risk groups.
- Clinical guidelines recommend cardiovascular risk evaluation before hospital discharge due to early post-infarction complications.
Purpose of the Study:
- To evaluate the role of radionuclide imaging in assessing myocardial viability.
- To highlight the cost-benefit advantages of radionuclide techniques.
- To integrate cardiac molecular, metabolic, and functional aspects for comprehensive patient assessment.
Main Methods:
- Utilizing radionuclide imaging for myocardial viability evaluation.
- Integrating molecular, metabolic, and functional cardiac data.
- Applying risk stratification models for post-myocardial infarction patients.
Main Results:
- Radionuclide imaging provides reliable and reproducible information on myocardial viability.
- The technique offers an attractive cost-benefit relationship.
- It enables a comprehensive assessment of cardiac aspects.
Conclusions:
- Radionuclide imaging is a valuable tool for myocardial viability assessment.
- Effective risk stratification aids in managing post-myocardial infarction patients.
- Early risk evaluation improves patient outcomes and guides treatment strategies.
More Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...